Anthony H Nguyen
Examiner (ID: 17425)
Most Active Art Unit | 2854 |
Art Unit(s) | 3307, 2854, 2853 |
Total Applications | 2014 |
Issued Applications | 1600 |
Pending Applications | 48 |
Abandoned Applications | 337 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 7103675
[patent_doc_number] => 20050106401
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-19
[patent_title] => 'Functionalized silicon surfaces'
[patent_app_type] => utility
[patent_app_number] => 11/010100
[patent_app_country] => US
[patent_app_date] => 2004-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 4988
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20050106401.pdf
[firstpage_image] =>[orig_patent_app_number] => 11010100
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/010100 | Functionalized silicon surfaces | Dec 9, 2004 | Issued |
Array
(
[id] => 6983266
[patent_doc_number] => 20050153336
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-14
[patent_title] => 'Compositions and their uses directed to nucleic acid binding proteins'
[patent_app_type] => utility
[patent_app_number] => 11/004127
[patent_app_country] => US
[patent_app_date] => 2004-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28272
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20050153336.pdf
[firstpage_image] =>[orig_patent_app_number] => 11004127
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/004127 | Compositions and their uses directed to nucleic acid binding proteins | Dec 2, 2004 | Abandoned |
Array
(
[id] => 4464472
[patent_doc_number] => 07935677
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-03
[patent_title] => 'Polymalic acid-based multi-functional drug delivery system'
[patent_app_type] => utility
[patent_app_number] => 10/580999
[patent_app_country] => US
[patent_app_date] => 2004-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 14235
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/935/07935677.pdf
[firstpage_image] =>[orig_patent_app_number] => 10580999
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/580999 | Polymalic acid-based multi-functional drug delivery system | Dec 2, 2004 | Issued |
Array
(
[id] => 6959290
[patent_doc_number] => 20050215503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-29
[patent_title] => 'HIF oligonucleotide decoy molecules'
[patent_app_type] => utility
[patent_app_number] => 11/003907
[patent_app_country] => US
[patent_app_date] => 2004-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 16087
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20050215503.pdf
[firstpage_image] =>[orig_patent_app_number] => 11003907
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/003907 | HIF oligonucleotide decoy molecules | Dec 1, 2004 | Abandoned |
Array
(
[id] => 4921971
[patent_doc_number] => 20080070286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-20
[patent_title] => 'Dna Participating in Hydroxylation of Macrolide Compound'
[patent_app_type] => utility
[patent_app_number] => 10/577655
[patent_app_country] => US
[patent_app_date] => 2004-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19437
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20080070286.pdf
[firstpage_image] =>[orig_patent_app_number] => 10577655
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/577655 | DNA participating in hydroxylation of macrolide compound | Nov 24, 2004 | Issued |
Array
(
[id] => 7186703
[patent_doc_number] => 20050125847
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-09
[patent_title] => 'Use of coral red fluorescence proteins as tracers for easy identification of genetic modified Baculoviruses'
[patent_app_type] => utility
[patent_app_number] => 10/995708
[patent_app_country] => US
[patent_app_date] => 2004-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3371
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0125/20050125847.pdf
[firstpage_image] =>[orig_patent_app_number] => 10995708
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/995708 | Use of coral red fluorescence proteins as tracers for easy identification of genetic modified Baculoviruses | Nov 22, 2004 | Abandoned |
Array
(
[id] => 5770354
[patent_doc_number] => 20050266422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-01
[patent_title] => 'Fluoroalkoxy, nucleosides, nucleotides, and polynucleotides'
[patent_app_type] => utility
[patent_app_number] => 10/981966
[patent_app_country] => US
[patent_app_date] => 2004-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 62535
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20050266422.pdf
[firstpage_image] =>[orig_patent_app_number] => 10981966
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/981966 | Fluoroalkoxy, nucleosides, nucleotides, and polynucleotides | Nov 4, 2004 | Abandoned |
Array
(
[id] => 7097318
[patent_doc_number] => 20050129776
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => 'Microparticles supporting cells and active substances'
[patent_app_type] => utility
[patent_app_number] => 10/980384
[patent_app_country] => US
[patent_app_date] => 2004-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7910
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20050129776.pdf
[firstpage_image] =>[orig_patent_app_number] => 10980384
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/980384 | Microparticles supporting cells and active substances | Nov 2, 2004 | Abandoned |
Array
(
[id] => 5254061
[patent_doc_number] => 20070135517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-14
[patent_title] => 'Antitumor medicine'
[patent_app_type] => utility
[patent_app_number] => 10/577447
[patent_app_country] => US
[patent_app_date] => 2004-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 3224
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20070135517.pdf
[firstpage_image] =>[orig_patent_app_number] => 10577447
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/577447 | Antitumor medicine | Oct 27, 2004 | Issued |
Array
(
[id] => 7146547
[patent_doc_number] => 20050119473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-02
[patent_title] => 'Phosphite ester oxidation in nucleic acid array preparation'
[patent_app_type] => utility
[patent_app_number] => 10/974287
[patent_app_country] => US
[patent_app_date] => 2004-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11097
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20050119473.pdf
[firstpage_image] =>[orig_patent_app_number] => 10974287
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/974287 | Phosphite ester oxidation in nucleic acid array preparation | Oct 25, 2004 | Abandoned |
Array
(
[id] => 5738423
[patent_doc_number] => 20060008813
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-12
[patent_title] => 'Compositions and methods of synthesis and use of novel nucleic acid structures'
[patent_app_type] => utility
[patent_app_number] => 10/966672
[patent_app_country] => US
[patent_app_date] => 2004-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 17942
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20060008813.pdf
[firstpage_image] =>[orig_patent_app_number] => 10966672
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/966672 | Compositions and methods of synthesis and use of novel nucleic acid structures | Oct 13, 2004 | Abandoned |
Array
(
[id] => 6938496
[patent_doc_number] => 20050112059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Enhancement of radiotherapy by an exogenous cardiac glycoside'
[patent_app_type] => utility
[patent_app_number] => 10/957875
[patent_app_country] => US
[patent_app_date] => 2004-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3307
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20050112059.pdf
[firstpage_image] =>[orig_patent_app_number] => 10957875
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/957875 | Enhancement of radiotherapy by an exogenous cardiac glycoside | Oct 3, 2004 | Abandoned |
Array
(
[id] => 236320
[patent_doc_number] => 07595301
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-29
[patent_title] => 'Staple type oligonucleotide and drug comprising the same'
[patent_app_type] => utility
[patent_app_number] => 10/568226
[patent_app_country] => US
[patent_app_date] => 2004-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2568
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/595/07595301.pdf
[firstpage_image] =>[orig_patent_app_number] => 10568226
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/568226 | Staple type oligonucleotide and drug comprising the same | Sep 28, 2004 | Issued |
Array
(
[id] => 6972789
[patent_doc_number] => 20050038499
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-17
[patent_title] => 'Methods for coating stents with DNA and expression of recombinant genes from DNA coated stents in vivo'
[patent_app_type] => utility
[patent_app_number] => 10/946785
[patent_app_country] => US
[patent_app_date] => 2004-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3302
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20050038499.pdf
[firstpage_image] =>[orig_patent_app_number] => 10946785
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/946785 | Methods for coating stents with DNA and expression of recombinant genes from DNA coated stents in vivo | Sep 21, 2004 | Abandoned |
Array
(
[id] => 8834333
[patent_doc_number] => 08450088
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-28
[patent_title] => 'Process for producing CMP-N-acetylneuraminic acid'
[patent_app_type] => utility
[patent_app_number] => 10/573385
[patent_app_country] => US
[patent_app_date] => 2004-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5131
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 237
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10573385
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/573385 | Process for producing CMP-N-acetylneuraminic acid | Sep 20, 2004 | Issued |
Array
(
[id] => 13063
[patent_doc_number] => 07803397
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-09-28
[patent_title] => 'Polyethyleneglycol-modified lipid compounds and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/942379
[patent_app_country] => US
[patent_app_date] => 2004-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 24728
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/803/07803397.pdf
[firstpage_image] =>[orig_patent_app_number] => 10942379
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/942379 | Polyethyleneglycol-modified lipid compounds and uses thereof | Sep 14, 2004 | Issued |
Array
(
[id] => 5199163
[patent_doc_number] => 20070298481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-27
[patent_title] => 'Method for Producing a Useful Intermediate in Alkaloid Biosynthesis By Using Rnai Technology'
[patent_app_type] => utility
[patent_app_number] => 10/572395
[patent_app_country] => US
[patent_app_date] => 2004-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 5764
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20070298481.pdf
[firstpage_image] =>[orig_patent_app_number] => 10572395
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/572395 | Method for Producing a Useful Intermediate in Alkaloid Biosynthesis By Using Rnai Technology | Sep 14, 2004 | Abandoned |
Array
(
[id] => 6991483
[patent_doc_number] => 20050090520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-28
[patent_title] => 'Treatment of disease or injury of the nervous system with FTY720'
[patent_app_type] => utility
[patent_app_number] => 10/938491
[patent_app_country] => US
[patent_app_date] => 2004-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 16973
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0090/20050090520.pdf
[firstpage_image] =>[orig_patent_app_number] => 10938491
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/938491 | Treatment of disease or injury of the nervous system with FTY720 | Sep 9, 2004 | Abandoned |
Array
(
[id] => 6939762
[patent_doc_number] => 20050113325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Modified oligonucleotides for telomerase inhibition'
[patent_app_type] => utility
[patent_app_number] => 10/938184
[patent_app_country] => US
[patent_app_date] => 2004-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 14202
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20050113325.pdf
[firstpage_image] =>[orig_patent_app_number] => 10938184
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/938184 | Modified oligonucleotides for telomerase inhibition | Sep 8, 2004 | Issued |
Array
(
[id] => 4893350
[patent_doc_number] => 20080102448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-01
[patent_title] => 'Novel Vector And Utilization Of The Same'
[patent_app_type] => utility
[patent_app_number] => 10/570511
[patent_app_country] => US
[patent_app_date] => 2004-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 26852
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0102/20080102448.pdf
[firstpage_image] =>[orig_patent_app_number] => 10570511
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/570511 | Vector and utilization of the same | Aug 30, 2004 | Issued |